Search

Displaying results 5111 - 5120 of 10000 in total
  1. Drug

    Angelica sinensis root

    go.drugbank.com/drugs/DB14336
    Investigational

    Angelica sinensis root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Categories: Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 Enzyme Inhibitors
  2. Drug

    Salvia miltiorrhiza root

    go.drugbank.com/drugs/DB14337
    Investigational

    Salvia miltiorrhiza root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  3. Drug

    Forsythia suspensa fruit

    go.drugbank.com/drugs/DB14345
    Investigational

    Forsythia suspensa fruit is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Mentha arvensis top

    go.drugbank.com/drugs/DB14346
    Investigational

    Mentha arvensis top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  5. Drug

    Apple fruit oil

    go.drugbank.com/drugs/DB14355
    Investigational

    Apple fruit oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Moringa oleifera leaf

    go.drugbank.com/drugs/DB14362
    Investigational

    Moringa oleifera leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  7. Drug

    Capsicum annuum whole

    go.drugbank.com/drugs/DB14368
    Investigational

    Capsicum annuum whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  8. Drug

    Branaplam

    go.drugbank.com/drugs/DB14918
    Investigational

    Branaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)).

  9. Drug

    Recombinant CD40-ligand

    go.drugbank.com/drugs/DB15015
    Investigational

    Recombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).

  10. Drug

    Eftilagimod alfa

    go.drugbank.com/drugs/DB16150
    Investigational

    Eftilagimod alfa is under investigation in clinical trial NCT02614833 (IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma).